In the pursuit of gains in muscle size and strength, body-builders may mistakenly use illicit drugs believing them to be anabolic steroids. The case described illustrates the physical and psychological dangers of such behaviour.
Anabolic steroids are widely used in body-building for gains in muscle size and strength" 2. The adverse effects which might be brought into the physician's waiting room are relatively well-documented. However, the psychiatric effects are not as clearly examined. Although some studies have noted irritability or euphoria in association with anabolic steroid use, only four reports have described more serious psychiatric problems. The first3 described a 17-yearold male bodybuilder who developed depression, paranoid ideation, and 'audible thoughts' about 6 months after starting a regimen of unknown anabolic steroids obtained illicitly. The second4 reported a 27-year-old male bodybuilder who developed euphoria, irritability, racing thoughts and hyperactivity within a few days of starting oral oxandrolone, 6 mg twice daily. A third report' described paranoid symptoms in four of five depressed men within a few days of taking imipramine plus methyltestosterone. In all four patients, the paranoid symptoms resolved promptly when methyltestosterone was stopped.
A case is described which has subtle differences from those described above.
Case report
A general practitioner requested psychiatric opinion for a 30-year-old man known to be taking anabolic steroids for body building. The patient presented with severe acute depression with suicidal ideas after the purchase and injection of Haldol Decanoate (Janssen Pharmaceuticals, Wantage, UK) some steroid. In the interim period the GP had prescribed dothiapen and propranolol, but the depression had persisted.
When seen by the psychiatrist, the patient admitted that he had also taken Periactin (Merck, Sharp and Dohme, Hoddesdon, UK) as an appetite stimulant. He complained of feeling profoundly depressed and suicidal, lacking energy but restless. After the injection he had experienced severe extrapyramidal symptoms and had 'slept for 4 days'.
At interview, he presented as depressed and anxious with hypochondriacal fears about permanent effects of the medication. Despite his subjective motor restlessness there were no overt extrapyramidal symptoms on examination. Procyclidine was prescribed and day-care initiated. Some 3 days later the patient presented in crisis, emotionally distressed and complaining of akathisia (motor restlessness). He was given procyclidine intramuscularly with good effect. While the physical symptoms presented no further problems, he continued to have persistent reactive psychiatric difficulties, with loss of confidence and low self-esteem for at least the next 9 months.
Discussion
In this instance, the Haldol Decanoate was sold and mistakenly purchased as nandrolone decanoate on the basis that the common base decanoate represented the anabolic steroid. Unfortunately, the preparation not only contained a powerful injectable neuroleptic but an ester designed to produce sustained release of haloperidol over a period of up to 4 weeks.
Anabolic steroid abuse is on the increase, especially over the last 5 years. A preliminary survey by one of the authors (Perry) indicates a 38.8% prevalence in some gymnasia. The case described not only highlights problems which may be encountered when seeing patients taking anabolic steroids, but also problems which might be encountered by patients who are taking what they mistakenly think are anabolic steroids. In comparison with illicit drug misusers, individuals who abuse anabolic steroids appear to possess relatively little knowledge of the pharmacological substances they are injecting. In- 
